Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter study-Reference-Cited by-同舟云学术

Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter study

Published:2019-12-17 Issue:3 Volume:4 Page:497-502
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Kuwashiro Takuya¹²,Takahashi Hirokazu¹²,Hyogo Hideyuki³,Ogawa Yuji⁴,Imajo Kento⁴,Yoneda Masato⁴,Nakahara Takashi⁵,Oeda Satoshi¹,Tanaka Kenichi²,Amano Yuichiro⁶,Ogawa Shinji⁶,Kawaguchi Atsushi⁷,Aishima Shinichi⁸,Kage Masayoshi⁹,Chayama Kazuaki⁵,Nakajima Atsushi³,Eguchi Yuichiro¹

Affiliation:

1. Liver CenterSaga University Hospital Saga Japan

2. Division of Metabolism and Endocrinology, Faculty of MedicineSaga University Saga Japan

3. Department of Gastroenterology and HepatologyJA Hiroshima General Hospital Hiroshima Japan

4. Department of Gastroenterology and HepatologyYokohama City University Graduate School of Medicine Yokohama Japan

5. Department of Gastroenterology and Metabolism, Institute of Biomedical & Health SciencesHiroshima University Hiroshima Japan

6. Takeda Pharmaceutical Company, Ltd. Fujisawa Kanagawa Japan

7. Section of Clinical Cooperation System, Center for Comprehensive Community Medicine, Faculty of MedicineSaga University Saga Japan

8. Department of Pathology and Microbiology, Faculty of MedicineSaga University Saga Japan

9. Kurume University Research Center for Innovative Cancer Therapy Kurume Japan

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12289

Reference48 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

3. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

4. Long-term follow-up of patients with NAFLD and elevated liver enzymes

5. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver fat volume fraction measurements based on multi-material decomposition algorithm in patients with nonalcoholic fatty liver disease: the influences of blood vessel, location, and iodine contrast;BMC Medical Imaging;2024-02-07

2. Metabolic Dysfunction-Associated Steatohepatitis Detected by Neutrophilic Crown-Like Structures in Morbidly Obese Patients: A Multicenter and Clinicopathological Study;Research;2024-01

3. Evaluation of minimum-to-severe global and macrovesicular steatosis in human liver specimens: a portable ambient light-compatible spectroscopic probe;2023-12-04

4. Semaglutide in NASH-related cirrhosis: still a long way to go? – Authors' reply;The Lancet Gastroenterology & Hepatology;2023-08

5. Semaglutide in NASH-related cirrhosis: still a long way to go? – Authors' reply;The Lancet Gastroenterology & Hepatology;2023-08